Abstract
Biochemical determination of hormone receptors in carcinomas is influenced by the potential heterogeneity of the tissue samples. In order to check this, samples of 16 breast cancers were divided into 6 segments. These segments were alternately examined for their ratio of tumor tissue to connective tissue ("percentage of carcinoma") or for the content of estrogen and progesterone receptors. Only 3 of the tumors were homogeneous, and 9 of the heterogeneous tissues had hormone receptors. The segment with the maximum "percentage of carcinoma" was adjacent to that with the peak value of hormone receptors in all but 1 tissue. The same applied to the minima. The maximum and minimum values of estrogen and progesterone receptors were located within the same segment in all but one tissue sample. The results demonstrated that biochemical assay of hormone receptors is reliable. A reduction of the sample volume does not enhance the precision of the receptor assay, since it increases the possibility of a false negative result.
MeSH Terms
Adenocarcinoma, Mucinous/metabolism,pathology
Breast Neoplasms/metabolism,pathology
Carcinoma, Intraductal, Noninfiltrating/metabolism,pathology
Female
Humans
Receptors, Estrogen/analysis
Receptors, Progesterone/analysis
Chemicals
Receptors, Estrogen
Receptors, Progesterone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Geyer H
Eberl M
Hornberger B
References (10)
10 references, click to expand
-
The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update.
Cancer. 1980 Dec 15;46(12 Suppl):2794-6
PMID: 7448723
-
Specific estrogen binding by the cytoplasm fof human breast carcinoma.
J Clin Endocrinol Metab. 1970 May;30(5):639-45
PMID: 4315481
-
Inter-site variation of oestrogen receptors in human breast cancers.
Br J Cancer. 1978 Oct;38(4):544-6
PMID: 728342
-
Hormone receptors: their role in predicting prognosis and response to endocrine therapy.
Semin Oncol. 1978 Dec;5(4):428-33
PMID: 734443
-
Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells.
Nature. 1984 Feb 23-29;307(5953):745-7
PMID: 6700704
-
The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.
Cancer. 1980 Dec 15;46(12 Suppl):2835-7
PMID: 7470229
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
Immunochemical studies of estrogen receptors.
J Steroid Biochem. 1984 Jan;20(1):51-6
PMID: 6200700
-
Clinical application of estrogen receptor in breast cancer.
Cancer. 1980 Dec 15;46(12 Suppl):2932-8
PMID: 7448740
-
Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.
Eur J Cancer. 1980 Jan;16(1):59-65
PMID: 7358078